Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent

Acta Crystallographica Section F: Structural Biology and Crystallization Communications

Volumn 63, Issue 7, 2007, Pages 599-601

  Li, Pengyun ^a   Rogers, Tanya ^a   Smiley, David ^a   DiMarchi, Richard D ^a   Zhang, Faming ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Diabetes; Exendin 4; Glucagon; Obesity

Indexed keywords

DRUG DERIVATIVE; GLUCAGON; PEPTIDE FRAGMENT;

ARTICLE; CRYSTALLIZATION; OBESITY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; GLUCAGON; OBESITY; PEPTIDE FRAGMENTS;

EID: 34447343314     PISSN: 17443091     EISSN: 17443091     Source Type: Journal    
DOI: 10.1107/S1744309107028655     Document Type: Article

References (19)

1. Bolli, G. B. (1984). Diabetologia, 27, 485.
2. Doyle, M. E., Theodorakis, M. J., Holloway, H. W., Bernier, M., Greig, N. H. & Egan, J. M. (2003). Regul. Pept. 114, 153-158.
3. Estall, J. L. & Drucker, D. J. (2006). Curr. Pharm. Des. 12, 1731-1750.
4. Fanelli, C. G., Porcellati, F., Rossetti, P. & Bolli, G. B. (2006). Nutr. Metab. Cardiovasc. Dis. 16, Suppl. 1, S28-S34.
5. Fehse, F., Trautmann, M., Holst, J. J., Halseth, A. E., Nanayakkara, N., Nielsen, L. L., Fineman, M. S., Kim, D. D. & Nauck, M. A. (2005). J. Clin. Endocrinol. Metab. 90, 5991-5997.
6. Gearhart, M. M. & Parbhoo, S. K. (2006). AACN Clin. Issues, 17, 50-55.
7. Goke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J. & Goke, B. (1993). J. Biol. Chem. 268, 19650-19655.
8. Jin, L., Briggs, S. L., Chandrasekhar, S., Chirgadze, N. Y., Clawson, D. K., Schevitz, R. W., Smiley, D. L., Tashjian, A. H. & Zhang, F. (2000). J. Biol. Chem. 275, 27238-27244.
9. Landsberg, L. (2006). Clin. Exp. Pharmacol. Physiol. 33, 863-867.
10. Larsen, P. J., Vrang, N. & Tang-Christensen, M. (2003). Curr. Pharm. Des. 9, 1373-1382.
11. Matthews, B. W. (1968). J. Mol. Biol. 33, 491-497.
12. Meier, J. J., Gallwitz, B., Schmidt, W. E. & Nauck, M. A. (2002). Eur. J. Pharmacol. 440, 269-279.
13. Murphy, K. G., Dhillo, W. S. & Bloom, S. R. (2006). Endocr. Rev. 27, 719-727.
14. Nauck, M. A. (1998). Acta Diabetol. 35, 117-129.
15. Nauck, M. A., Holst, J. J., Willms, B. & Schmiegel, W. (1997). Exp. Clin. Endocrinol. Diabetes, 105, 187-195.
16. Neidigh, J. W., Fesinmeyer, R. M., Prickett, K. S. & Andersen, N. H. (2001). Biochemistry, 40, 13188-13200.
17. Schepp, W., Schmidtler, J., Riedel, T., Dehne, K., Schusdziarra, V., Holst, J. J., Eng, J., Raufman, J. P. & Classen, M. (1994). Eur. J. Pharmacol. 269, 183-191.
18. Schnolzer, M., Alewood, P., Jones, A., Alewood, D. & Kent, S. B. (1992). Int. J. Pept. Protein Res. 40, 180-193.
19. Wyatt, S. B., Winters, K. P. & Dubbert, P. M. (2006). Am. J. Med. Sci. 331, 166-174.